The antidiabetic hormone adiponectin circulates in blood as several oligomeric complexes, and the ratios between them are critical in determining insulin sensitivity. In this study we investigated the role of testosterone in regulating the oligomeric complex distribution of adiponectin. Gel filtration analysis revealed that circulating adiponectin existed as the forms of high molecular weight (HMW), middle molecular weight, and low molecular weight complexes in both human and mice. The concentration of HMW adiponectin in female was significantly higher than that in male, whereas there were no gender differences for the other two forms. Castration induced a dramatic elevation of the HMW form but had no effect on either the middle molecular weight or the low molecular weight form in mice. Testosterone treatment, on the other hand, caused a specific reduction of HMW adiponectin in the circulation. Pulse-chase labeling experiments in rat adipocytes revealed that the three oligomeric forms of adiponectin were secreted into the culture medium at different rates and that testosterone selectively impeded the secretion of HMW adiponectin but not the other two forms. The inhibitory effect of testosterone on secretion of HMW adiponectin was largely restored by the transcription inhibitor actinomycin D, suggesting the involvement of a transcriptional event in this process. The selective inhibition of HMW adiponectin by testosterone might contribute to the sex dimorphism of adiponectin in terms of its oligomeric complex distribution and could partly explain why men have higher risk to insulin resistance and atherosclerosis than women.
Adiponectin is a circulating hormone predominantly secreted from adipose tissue (1) . Growing evidence suggests that adiponectin plays an important role in regulating systemic energy metabolism and insulin sensitivity (2, 3) . Adiponectin replacement therapy in mice can decrease hyperglycemia, induce a sustained body weight loss, and increase insulin sensitivity (4 -6) . We have recently reported that this protein can also ameliorate fatty liver diseases and lipid abnormalities associated with alcoholic consumption and obesity in mice by enhancing fatty acid oxidation and inhibiting the production of proinflammatory cytokine tumor necrosis factor ␣ in the liver tissue (7) .
In addition to its anti-diabetic effects, adiponectin possesses the direct anti-atherogenic properties. It can suppress foam cell formation by inhibiting macrophage scavenger receptor A expression and decreasing low density lipoprotein uptake (8) . In cultured smooth muscle cells adiponectin inhibits the proliferation and migration induced by many growth factors (9, 10) . The direct anti-atherogenic role of adiponectin was further confirmed by two recent in vivo studies that demonstrated that atherosclerosis in apoE-deficient mice is markedly alleviated by either injection of adenoviruses that express adiponectin (11) or by crossing the globular domain of adiponectin transgenic mice with apoE-deficient mice (10) . On the other hand, depletion of adiponectin gene expression causes moderate insulin resistance, glucose intolerance, and increases neointimal formation after mechanic injury (3, 10, 12) . A more recent study demonstrated that adiponectin may have utility for the treatment of hypertrophic cardiomyopathy associated with diabetes and other obesity-related diseases (13) .
Adiponectin structurally belongs to the complement C1q family that consists of an NH 2 -terminal collagen-repeat domain and a COOH-terminal globular head domain (14) . Gel filtration and velocity gradient centrifugation studies revealed that circulating adiponectin is predominantly present as several characteristic multimers (15) (16) (17) . The basic unit of the multimeric adiponectin is the trimer, also called low molecular weight (LMW) 1 adiponectin. Two subunits of the adiponectin trimer are linked by a disulfide bond mediated through a cysteine residue in the collagen-like domain to form a hexamer, a middle molecular weight (MMW) form of adiponectin (16, 18) . The hexamer provides the building block for the formation of a bouquet-like high molecular weight (HMW) adiponectin comprising 12-18 protomers. It has recently been suggested that different multimers of adiponectin might activate different signal transduction pathways and exert distinct functions on its target tissues. Tsao et al. (19) demonstrated that only the LMW form of adiponectin, but not the HMW or MMW form, stimulates AMP-activated protein kinase pathways in the muscle tissue. On the other hand, Pajvani et al. (20) showed that the HMW complex is the most active form of adiponectin in depressing blood glucose levels in mice. A more recent study from Kobayashi et al. (21) revealed that only HMW adiponectin selectively suppressed endothelial cell apoptosis, whereas neither the MMW nor the LMW form had this effect.
It has recently been proposed that the ratio of HMW/total adiponectin, but not the absolute amounts of adiponectin, determines insulin sensitivity in humans and rodents (20) . For instance, despite having similar total adiponectin levels with their wild-type littermates, db/db diabetic mice have a much lower percentage of the HMW form in the circulation. Clinical data also confirmed that patients with type 2 diabetes and coronary heart diseases have a selective reduction in HMW adiponectin (20, 21) . On the other hand, weight reduction or treatment with the insulin-sensitizing drug rosiglitazone preferentially elevates the HMW form of adiponectin but not the other two oligomeric complexes (20, 21) . More recently, Waki et al. (15) reported that serum from human subjects with rare missense mutations in adiponectin (G84R and G90S) was deficient in the HMW form of adiponectin. Notably, these mutations are associated with insulin resistance and Type 2 diabetes. These experimental and clinical data collectively suggest that the oligomeric complex distribution of adiponectin is critical for the anti-diabetic and anti-atherogenic activity of this hormone. Nevertheless, the molecular events that regulate the distribution of the adiponectin oligomeric complexes remain poorly characterized.
In this study we show that the sex hormone testosterone selectively reduces the circulating concentrations of HMW adiponectin by preferentially inhibiting its secretion from the fat tissue. Our results render a potential mechanistic explanation for the sexual dimorphism of adiponectin in terms of its oligomeric complex distribution and may also explain in part why males are more susceptible to diabetes and atherosclerosis than females.
EXPERIMENTAL PROCEDURES
Animal Maintenance and Experimental Protocol-8-Week-old male C57BL/6 mice weighing 20 -25 g were housed in stainless steel wirebottom cages on a 12-h light/dark cycle under institutional guidelines for the humane treatment of laboratory animals. Experiments of castration were performed under pentobarbital sodium anesthesia (50 mg/kg of body weight). After a midline abdominal incision, the testes were dissected out with epididymal fat pads and excised through an incision. The blood vessels supplying the testes were ligated, the fat pads were sent back, and the incision was closed with sutures. For the shammed controls, the surgical procedure was exactly the same except that the testes were not removed after exposure. The testosterone supplement study was conducted at 6 weeks after the operation. Castrated or sham-operated mice received a subcutaneous injection of testosterone propinate (5 mg/kg of body weight) every other day for 2 weeks. The control groups received the equal amount of vehicle (corn oil) only. The animals were then sacrificed under anesthesia, blood was obtained by cardiac puncture, and various tissues were collected for further analysis.
Human Subjects-Thirteen hypogonadal men with primary testicular failure (35.2 Ϯ 4.6 years, body mass index 26.3 Ϯ 2.6 kg/m 2 , mean Ϯ S.D.) were studied. Ten subjects had Klinefelter's syndrome, two had mumps orchitis, and one had aplasia. Blood samples were taken at base line and 3 months after testosterone replacement therapy. The study protocol was approved by the Ethics Committee of the Medical Faculty, the University of Hong Kong. Informed written consent was obtained from each subject.
Expression of Recombinant Human Adiponectin from HEK293 Cells-The gene encoding human adiponectin was amplified from the human adipocyte cDNA library (Clontech, Palo Alto, CA) using 5Ј-GC-CCGCGGATCCATGCTGTTGCTGGGAGCTGTTC-3Ј as the sense primer and 5Ј-GGCCGCGAATTCTCACTTGTCATCGTCGTCCTTGTA-GTCGTTGGTGTCATGGTAGAGAAG-3Ј as the antisense primer. After digestion with BamHI/EcoRI, the fragment was inserted into pcDNA3.1 to produce the expression vector pchAd-F, which encodes the full-length human adiponectin with a FLAG epitope tag at its COOH terminus.
HEK293 cells were transfected with pchAd-F and then subjected to selection using 1 mg/ml G418 to generate a cell line that stably expresses human adiponectin. The serum-free conditioned DMEM medium was harvested from these cells, and the FLAG-tagged human adiponectin was purified using anti-FLAG M2 monoclonal antibody affinity gel as we described previously (22) .
Generation of Monoclonal Antibodies against Human AdiponectinFemale BALB/c mice (8 weeks old) were repeatedly immunized with recombinant human adiponectin until the polyclonal sera from the mice exhibit strong immune responses. Splenocytes were then isolated from the mice and fused with the myeloma cells sp2/0. Screening and single cell cloning was conducted according to the established protocol. The positive clones were injected into immunocompromised BALB/c mice, and the immunoglobulin was purified from ascites using the protein G-coupled column. Two positive clones, namely hAd1f26 and hAd6b22, were chosen for the subsequent immunoassays.
Sandwich ELISA for Human and Murine Adiponectin-For measurement of human plasma adiponectin, the anti-human adiponectin mAb hAd1f26 was biotinylated with a kit from Pierce, and free biotin was removed by dialysis. The antibody hAd6b22 was diluted to a concentration of 2 g/ml, added to each well of a microtiter plate, and incubated overnight at 4°C. The coated plate was washed 3 times with PBS containing 1% bovine serum albumin and blocked with 100 l of PBS containing 1% bovine serum albumin and 0.05% Tween for 2 h. Human serum was diluted 1:5000, and 100 l of the diluted samples were applied to each well along with the standard, incubated at 37°C for 1 h, washed 3 times with PBS-Tween, and then incubated with 100 l of the biotinylated antibody hAd1f26 (2 g/ml) for another 2 h. After washing 3 times, the wells were incubated with streptavidin-conjugated horseradish peroxidase for 60 min and subsequently reacted with tetramethylbenzidine reagent for 15 min. 100 l of 2 M H 2 SO 4 was added to each well to stop the reaction, and the absorbance at 450 nm was measured. The intra-and interassay coefficients of variance were determined by measuring five plasma samples from healthy subjects in a total of six independent assays with duplicate determinations. Quantitative ELISA measurement of mouse serum adiponectin was conducted as we described previously (23) .
Gel Filtration and Quantification of Different Oligomeric Forms of Adiponectin-10 l of human or murine serum was diluted to 1 ml with PBS and loaded onto an AKTA explorer fast protein chromatography system, fractionated through a Hiload 16/60 Superdex 200 column (GE Healthcare), and eluted with PBS at the flow rate of 1 ml/min. Each 0.5-ml fraction was collected and subjected to ELISA analysis for human or murine adiponectin.
Isolation and Primary Culture of Rat Adipocytes-White fat precursor cells were isolated from the epididymal fat pad of 6-week-old male Wistar rats. Briefly, the minced tissue was incubated in a HEPESbuffered solution (pH 7.4) containing 0.2% collagenase type II (SigmaAldrich) for 20 min at 37°C with vortex every 5 min. After incubation, the tissue remnants were filtered through a 250-m nylon membrane into plastic test tubes. The tubes were placed on ice for at least 30 min to allow the mature white fat cells and lipid droplets to float on the surface of the cell suspension. The stromal-vascular fraction was collected and filtered through a 25-m nylon membrane to remove cell aggregates. The stromal vascular fraction containing precursor cells was pelleted by centrifugation for 10 min at 700 ϫ g and resuspended in the culture medium. The cells were plated in six-well multiplates and cultured in DMEM supplemented with 10% fetal bovine serum. Medium was changed every 2 days. Cells were maintained in this medium until confluence (usually 3 days). Differentiation was induced by the addition of medium supplemented with isobutylmethylxanthine (0.5 mmol/liter), dexamethasone (0.25 mol/liter), and insulin (10 g/ml). After 48 h the induction medium was removed and replaced by DMEM containing 10% fetal calf serum and insulin (10 g/ml). This medium was changed every 2 days. Ten days later cells were regarded as differentiated by morphologic criteria when, after acquiring a round shape, their cytoplasm was completely filled with multiple lipid droplets (assessed by oil red O staining). The cells were treated with either vehicle (0.1% ethanol) or different concentrations of testosterone in DMEM containing 0.5% bovine serum albumin for 24 h.
Metabolic Labeling and Immunoprecipitation-Differentiated rat adipocytes were pretreated with different concentrations of testosterone, estradiol, actinomycin D, or vehicle for 12 h, starved in methionineand cysteine-free DMEM for 1 h, and then replaced with the same fresh medium plus 50 Ci/ml of [ Both culture medium and cells were harvested for immunoprecipitation as we previously described (24) Briefly, cells were washed with PBS, solubilized in a IP buffer (25 mM HEPES with pH 7.5, 5 mM EDTA and EGTA, 100 mM NaCl, 10% glycerol, 1% Triton X-100, plus protease inhibitor cocktails), and the cell debris was removed by centrifugation (13,000 ϫ g, 5 min). All the cell lysates were adjusted to an equal protein concentration (0.5 g/l) with IP buffer. 600 l of cell lysates from each treatment was preincubated with 50 l of protein A/G beads (GE Healthcare) for 1 h to clarify nonspecific bindings. The supernatants were incubated with 10 g of the rabbit anti-mouse adiponectin IgG overnight at 4°C with shaking, and 50 l of protein A/G beads was then added into the supernatant for another 1 h. The beads were precipitated and washed with IP buffer three times, and the immunoprecipitated complexes were eluted by incubation with a non-reducing SDS-PAGE loading buffer. The eluted samples were separated by 4 -20% gradient SDS-PAGE and then analyzed by phosphorimaging (BAS 2000; Fujifilm) . The radioactivity associated with each band was quantified as we previously described (25) .
Western Blotting Analysis of Oligomeric Adiponectin Complexes-1 l of mouse serum samples from male or female mice were incubated with a non-reducing sample buffer (1% SDS, 5% glycerol, and 10 mM Tris-HCl with pH 6.8) at room temperature for 10 min, separated by a 4 -20% gradient SDS-PAGE, and immunoblotted with horseradish peroxidase-conjugated rabbit anti-mouse adiponectin antibody as we previously described (22) .
Statistical Analysis-Experiments were performed routinely with 4 -6 mice per group with values presented as the mean Ϯ S.E. All the studies were replicated with representative data shown. Statistical significance was determined by one-way analysis of variance or Pearson's correlation coefficient test. In all statistical comparisons, a p value of less than 0.05 was used to indicate a significant difference.
RESULTS

Sexually Dimorphic Distribution of the Adiponectin Oligomeric Complexes in Mice-
In line with a previous study (26) , our result demonstrated that the serum levels of total adiponectin in C57 female mice was significantly higher than the age-and body weight-matched male mice (16.7 Ϯ 2.8 versus 9.6 Ϯ 1.7 g/ml, p Ͻ 0.01). A non-heating and non-reducing SDS-PAGE analysis resolved mouse serum adiponectin into three distinct bands (Fig. 1A) that represent the three oligomeric forms of adiponectin (15) . The upper band, with an apparent molecular weight of Ͼ250, is equivalent to HMW adiponectin. The middle band (ϳ180) and the lower band (ϳ90) are MMW and LMW adiponectin, respectively. Gel filtration analysis also separated mouse serum adiponectin into three major oligomeric forms, which eluted at 45.5-49, 52.5-56.5, and 58.5-62 min, respectively (Fig. 1B) . SDS-PAGE analysis revealed that the adiponectin eluted in the first major peak is predominantly its HMW form, whereas adiponectin in the fractions of the second and the third peaks are its MMW and LMW forms, respectively (Fig. 1C) . The concentration of the HMW form of adiponectin in females was substantially higher than that in males, whereas the concentrations of both MMW and LMW forms of adiponectin are similar between the two genders. Accordingly, females had a significantly higher percentage composition of the HMW form but a relatively lower percentage composition of the MMW form and the LMW form per total adiponectin than males (Fig. 1D) . These results suggest that the sexual dimorphism of adiponectin is primarily due to the difference of HMW adiponectin but not the other two oligomeric forms.
Castration and Testosterone Treatment Selectively Modulates Circulating Concentrations of HMW Adiponectin and Alters the Pattern of Adiponectin Oligomeric Complex Distribution-
We next investigated the effect of castration and testosterone treatment on total adiponectin and patterns of adiponectin oligomeric complex distribution in mice. In line with a previous report (27) , we found that castration and testosterone treatment did not affect body weight and weight of fat pads in different anatomical locations (data not shown).
Castration decreased the weight of kidney and prostate, whereas testosterone treatment had the opposite effect (data not shown). The serum levels of total adiponectin were increased after castration and were decreased after testosterone treatment of both sham-operated and castrated mice ( Fig. 2A) . Gel filtration analysis for the oligomeric complex distribution of adiponectin showed that castration selectively increased the circulating concentrations of HMW adiponectin but had little effect on that of either the MMW or the LMW adiponectin (Fig. 2B) . On the other hand, treatment of both sham-operated mice and castrated mice with testosterone preferentially decreased the circulating concentration of HMW adiponectin but not the other two oligomeric complexes. Accordingly, castration increased the percentage composition of the HMW form and relatively decreased those of the MMW and LMW forms per total adiponectin (Fig. 2C) . Testosterone treatment had the opposite effects.
In contrast with those in serum, neither castration nor testosterone treatment had obvious effects on the intracellular pattern of adiponectin oligomeric complex distribution in fat tissues (Fig. 3) . Notably, HMW adiponectin accounted for nearly 65% of the total adiponectin in fat pads under different treatments, which was significantly higher than that observed in the circulation (Fig. 2D) . On the other hand, the percentage compositions of MMW and LMW adiponectin inside the fat tissue were relatively lower than those in the circulation. The differential pattern of adiponectin oligomeric complex distribution between the fat tissue and serum suggests that the three oligomeric forms of adiponectin might be secreted into the circulation with different rates. 
Testosterone Directly Inhibits the Secretion of the HMW Form of Adiponectin from Rat Adipocytes through Transcriptional
Regulation-We next investigated the direct effect of testosterone on secretion and intracellular assembly of adiponectin oligomeric complexes in rat adipocytes. To this end, stromalvascular cells isolated from rat epididymal fat pads were differentiated into mature adipocytes, which were then treated with 250 nM testosterone or vehicle (ethanol) for a period of 24 h. Gel filtration analysis revealed that adiponectin in the conditioned medium of adipocytes was also present as the HMW, MMW, and LMW forms, which accounted for 33.6, 45.2 and 21.2% of total adiponectin, respectively (Fig. 4, upper  panel) . In contrast, the percentage composition of the HMW form retained inside the adipocytes accounts for 66.4% of the total adiponectin (Fig. 4, lower panel) , which was significantly higher than that secreted into the conditioned culture medium (p Ͻ 0.01). This result further confirms our in vivo finding that the three adiponectin oligomeric complexes have differential secretion efficiency, with the HMW form of adiponectin selectively retarded inside the cells.
Testosterone treatment did not influence mRNA abundance of the adiponectin gene or production of total adiponectin protein from the adipocytes (data not shown). On the other hand, testosterone preferentially reduced the concentrations of HMW adiponectin and relatively elevated the percentage compositions of the other two oligomeric forms in conditioned culture medium (Fig. 4, upper panel) . In contrast, this treatment caused a slight, but not significant increase in the percentage composition of HMW adiponectin inside the adipocytes (Fig. 4,  lower panel) . These results suggest that testosterone-mediated reduction of HMW adiponectin in the conditioned culture medium is not due to the impaired intracellular assembly but perhaps due to the attenuated secretion. Treatment of cells
FIG. 2.
Opposite effects of castration and testosterone treatment on serum levels of total adiponectin and patterns of its oligomeric complex distribution in mice. C57 male mice were castrated or sham-operated as described under "Experimental Procedures." Six weeks after operation mice were treated with testosterone or corn oil (vehicle control) for another 2 weeks. The serum levels of total adiponectin were quantified by ELISA (A), and the pattern of adiponectin oligomeric complex distribution was analyzed by gel filtration (B). C, percentage composition of each oligomeric form of adiponectin versus total adiponectin. CO, castrated mice treated with corn oil; CT, castrated mice treated with testosterone; SO, sham-operated mice treated with corn oil; ST, sham-operated mice treated with testosterone. p Ͻ 0.05 (*) and p Ͻ 0.01 (**) versus the SO group; p Ͻ 0.05 (#) and p Ͻ 0.01 (##)versus the SO or CO group; p Ͻ 0.05 ($) and p Ͻ 0.01 ($$) versus the SO or CO group.
FIG. 3.
Castration and testosterone treatment had no effect on intracellular oligomeric complex distribution of adiponectin in mouse fat pads. Mice were sham-operated or castrated and subsequently treated with testosterone or corn oil. Epididymal fat pads were excised and dissolved in a phosphate buffer with 1.5% Triton X-100. The cell debris was removed by centrifugation. Equal protein amounts of the cell lysates were then fractionated by gel filtration, and the percentage of each oligomeric form versus total adiponectin was calculated as in Fig. 2 . Note that castration and testosterone treatment did not affect the pattern of adiponectin oligomeric complex distribution in subcutaneous, inguinal, intrascapular, and brown fat pads (data not shown). with the transcription inhibitor actinomycin D alone did not affect either the intracellular assembly or the secretion of the HMW form of adiponectin. On the other hand, co-incubation of cells with actinomycin D and testosterone largely restored testosterone-induced selective reduction of HMW adiponectin in the conditioned medium, suggesting that a transcriptional event is involved in testosterone-mediated selective reduction of HMW adiponectin. Estrogen had no effect on the percentage composition of each oligomeric complex of adiponectin either inside the cells or in the conditioned medium.
We next conducted a pulse-chase experiment in combination with immunoprecipitation to dynamically monitor the secretion process of different adiponectin oligomeric complexes in rat adipocytes. To this end, rat adipocytes were pulse-labeled with [ 35 S]methionine and [ 35 S]cysteine for 2 h and then chased in a "cold" medium for different time periods. Cell lysates and culture medium were collected and subjected to immunoprecipitation using the anti-mouse adiponectin antibody as we previously described (28) . A non-heating and non-reducing SDS-PAGE analysis revealed that all the three oligomeric complexes of adiponectin were immunoprecipitated by the rabbit anti adiponectin IgG (Fig. 5) but not the pre-immune IgG (data not shown). The secretion of newly synthesized HMW adiponectin is much slower than that of MMW and LMW adiponectin at several time points. At 15 h after chase, almost all of the MMW and LMW forms of adiponectin synthesized during the 2-h pulse-labeling period were released into the culture media, whereas there was still more than 30% of HMW adiponectin retained inside the cells. Testosterone treatment selectively decreased the secretion of HMW adiponectin throughout the chasing period but had no effect on secretion of either MMW or LMW adiponectin.
Further pulse-chase analysis revealed that testosterone exerted its inhibitory effect on secretion of HMW adiponectin in a dose-dependent manner (Fig. 6) . The significant effect was observed at 25 nM, and the maximal inhibition was found at 250 nM. Treatment with actinomycin D drastically attenuated the inhibitory effect of testosterone on secretion of HMW adiponectin. On the other hand, estrogen had little effect on secretion of HMW adiponectin from rat adipocytes.
Testosterone Replacement Therapy Preferentially Decreases the Percentage Composition of the HMW Form of Adiponectin in
Humans-To establish an in-house sandwich immunoassay for analysis of circulating levels of total human adiponectin and the distribution of its different oligomeric complexes, we expressed and purified FLAG-tagged recombinant human adiponectin from HEK293 cells (see the supplemental figure). Gel filtration analysis showed that recombinant adiponectin secreted from HEK293 cells also existed as three oligomeric complexes (data not shown). Two anti-human adiponectin monoclonal antibodies (hAd6b22 and hAd1f26) were then generated using the recombinant human adiponectin as the antigen. Western blot analysis showed that the antibody hAd6b22 could recognize serum adiponectin from multiple species such as human, rat, horse, and bovine, whereas hAd1f26 exclusively recognize human adiponectin (data not shown). The sandwich ELISA standard curve using the human recombinant adiponectin yielded a consistent r 2 value greater than 0.980. This assay was able to detect as little as 150 pg/ml human adiponectin, with the interassay and intraassay coefficients of variance at 6.2-8.3 and 5.1-6.4%, respectively.
Serum levels of total adiponectin were significantly higher in female than body mass index-and age-matched male (10.37 Ϯ 2.46 versus 7.21 Ϯ 1.93 g/ml, p Ͻ 0.01). Gel filtration analysis demonstrated that human serum adiponectin was also present as the three oligomeric complexes (Fig. 7A) , a pattern similar with that of mouse adiponectin. However, unlike mouse adiponectin, the LMW form of human adiponectin was very low, accounting for ϳ10% of the total adiponectin (Fig. 7B) . The percentage composition of the HMW form versus total adiponectin was higher in women than in men, whereas men had a relatively higher percentage of MMW and LMW forms of adiponectin than women.
To investigate the role of testosterone on adiponectin oligomeric complex distribution in human subjects, we analyzed serum samples from 13 hypogonadal patients with primary testicular failure. The subjects received a testosterone transdermal patch daily for a period of 12 weeks. After the testosterone replacement therapy, serum testosterone levels increased to within the normal range in all the subjects (4.9 Ϯ 2.1 at base line versus 19.9 Ϯ 12.1 nM at 3 months). Testosterone replacement therapy caused a modest but not significant decrease in their body mass index (26.3 Ϯ 2.6 at base line versus 24.4 Ϯ 2.8 kg/m 2 at 3 months). The serum levels of total adiponectin were modestly but significantly decreased (Fig.  8A) . Notably, this treatment substantially decreased the percentage composition of HMW adiponectin, whereas the percentage compositions of the MMW and LMW forms of adiponectin were relatively elevated (Fig. 8B) . This result suggests that testosterone selectively reduces the circulating concentrations of HMW adiponectin and modulates the pattern of adiponectin oligomeric complex distribution in man.
DISCUSSION
Earlier reports have revealed the sexual dimorphism of adiponectin, with females having significantly higher circulating levels of total adiponectin than males in both humans and rodents (26, 27, 29) . Gender differences of total adiponectin develop during the progression of puberty. A recent study on human subjects have found that total adiponectin levels decline in parallel with physical and pubertal development in boys, subsequently leading to significantly reduced circulating concentrations of this protein in adolescent boys compared with girls (30) . In contrast with humans, total adiponectin levels increase during sexual differentiation in mice (26) . The magnitude of adiponectin increases in females during puberty is much higher than that in males. In this study we show that the sexual dimorphism of adiponectin is mainly due to the difference in its HMW form in both humans and rodents, whereas females and males have comparable levels of the MMW and LMW forms. In line with our result, a recent study using FIG. 7 . Sexual dimorphism of adiponectin in terms of its oligomeric complex distribution in human serum. 10 l of serum from males or age-and body mass index-matched females was subjected to fractionation using gel filtration chromatography. Human adiponectin concentrations in each fraction were quantified using an in-house ELISA assay. A, the representative distribution profile of different oligomeric form of adiponectin. B, the percentage composition of each oligomeric form of adiponectin versus the total adiponectin. p Ͻ 0.05 (*) and p Ͻ 0.01 (**) versus males. velocity ultracentrifugation also observed that the percentage composition of HMW adiponectin in female mice is significantly higher than that in male mice (16) . Clinical studies have found that decreased ratios of HMW/total adiponectin are closely associated with the development of diabetes and cardiovascular diseases (20, 21) . Given the important role of HMW adiponectin in increasing insulin sensitivity and in preventing atherosclerosis, the sexual difference in HMW adiponectin might partly explain the fact that men have a higher incidence of atherosclerosis and are more susceptible to insulin resistance than women (31, 32) .
Testosterone has recently been shown to be a negative regulator of adiponectin production in both rodents and humans. Combs et al. (26) have shown that abrogation of androgen effects through neonatal castration increases serum levels of total adiponectin comparable with those in females, whereas ovariectomy did not influence the pubertal rise of total adiponectin. In contrast, another study by Nishizawa et al. (27) has demonstrated an elevation of total adiponectin levels in castrated adult but not neonatal mice that decreased after testosterone was replaced. A more recent clinical report has shown that hypogonadal men have significantly higher plasma concentrations of total adiponectin, which are reduced after testosterone replacement therapy (33) . Nevertheless, the mechanisms that underlie the regulatory effect of testosterone on adiponectin production are still poorly understood. Neither castration nor testosterone interferes with the mRNA abundance of the adiponectin gene in adipocytes (27, 34) , although these treatments modulate the serum levels of total adiponectin, suggesting that the regulation occurs at a posttranscriptional level. In this study we provide both experimental and clinical evidence demonstrating that testosterone exerts its regulatory actions at the level of adiponectin oligomeric complex distribution. This conclusion is supported by the fact that castration preferentially elevates the concentration of circulating HMW adiponectin but has no effects on the other two oligomeric complexes. On the other hand, testosterone treatment selectively reduces the circulating concentrations of HMW adiponectin in both rodents and human subjects.
Although the transcriptional regulation of adiponectin gene expression has recently been characterized in detail, the molecular events that control adiponectin oligomeric complex distribution remain largely uncharacterized. In this report we provide in vitro and in vivo evidence suggesting that testosterone-mediated selective reduction of HMW adiponectin in the circulation is due to its inhibitory effect on secretion of HMW adiponectin from adipocytes. Neither castration nor testosterone treatment decreases the contents of HMW adiponectin inside the fat tissue in vivo or adipocytes in vitro, suggesting that these treatments do not impair the intracellular assembly of HMW adiponectin. In fact, compared with those secreted in the culture medium or in the circulation, the intracellular ratios of HMW/total adiponectin in adipocytes is much higher, whereas the percentage compositions of the MMW and LMW adiponectin is relatively lower. Pulse-chase experiments reveal that the secretion of HMW adiponectin is much slower than the other two oligomeric complexes and that testosterone treatment further decreases the secretion of HMW adiponectin from adipocytes. Based on this evidence it is tempting to speculate that the three oligomeric complexes of adiponectin might be released from adipocytes via distinct secretory pathways, which renders it possible for testosterone to selectively impede the secretion of HMW adiponectin from adipocytes. In line with this hypothesis, a previous study has shown that the secretion of adiponectin from adipocytes involves at least two different secretory pathways, one for the constitutive secretion and another one for the regulated secretion of adiponectin (35) . Inhibitors of phosphatidylinositol 3-kinase (such as wortmannin and LY294002) were found to block insulin-stimulated but not basal secretion of adiponectin. Immunofluorescence microscopy data revealed that adiponectin is localized in at least two distinct compartments, which are different from the secretory pathways responsible for secretion of leptin, type IV collagen, and transferrin. Indeed, growing evidence suggests that adipocyte is an important endocrine cell that possesses a complex secretory machinery responsible for both constitutive and regulated secretion of a variety of adipokines, although very little is known regarding the components of these intracellular secretory pathways (36, 37) .
Testosterone is known to exert its actions through binding with its cognate nuclear receptor, which in turn transactivates its target genes by interacting with the specific cis elements of their promoters (38) . In this report, we show that pretreatment of adipocytes with the transcription inhibitor actinomycin D prevents testosterone-mediated-selective reduction of HMW adiponectin in the culture medium, suggesting that an additional factor(s), expression of which is under the control of testosterone, might be involved in blocking the secretion of HMW adiponectin from adipocytes. Notably, the peroxisome proliferator-activated receptor ␥ (PPAR␥) agonists, which also function through activation of its nuclear receptor and induction of PPAR␥-responsive gene expression, have recently been shown to selectively elevate the concentration of HMW adiponectin secreted into the culture medium of 3T3-L1 adipocytes (20) . These results collectively indicate that controlling the secretion of HMW adiponectin from adipocytes via transcriptional regulation might represent an important mechanism that modulates the bioavailability and activities of HMW adiponectin.
Testosterone replacement therapy in human subjects has previously been shown to decrease fat mass (especially visceral fat) possibly by increasing lipolysis of fat tissue (39) . Indeed, our present study also observed a modest, but not significant decrease of body mass index after testosterone treatment. Many cross-sectional studies have demonstrated that plasma levels of total adiponectin correlate inversely with fat mass (29, 40, 41) . Reduction of fat mass by weight loss or caloric restriction increases plasma levels of total adiponectin (42, 43) . In this connection, testosterone would be expected to elevate total adiponectin levels by decreasing fat mass. However, the results from our present study and others (44) have found that testosterone treatment causes reduction in total circulating adiponectin concentrations, suggesting that the direct inhibitory effects of testosterone on secretion of HMW from fat tissue might be predominant under this condition.
In summary, this study demonstrates for the first time that testosterone selectively reduces the circulating levels of HMW adiponectin by inhibiting its secretion from adipocytes. This finding renders a reasonable explanation for the sexual dimorphism of adiponectin in terms of its oligomeric complex distribution observed in humans and rodents. Androgens have been shown to be one of the causative factors for insulin resistance, coronary heart diseases, and hypertension in a number of previous studies (45, 46) . Selective reduction of HMW adiponectin might be one of the mechanisms that underlie the deleterious effects of this male-associated sex hormone. The results of this study further support the notion that regulation of adiponectin oligomeric complex distribution constitutes a key mechanism that controls the multiple biological activities of adiponectin. In light of the potential anti-diabetic and anti-atherogenic functions of HMW adiponectin suggested by many recent studies, further understanding of the secretory machinery and other
